First Detection of Ketoreductase in the Genome of Potentially Pathogenic Fast-Growing Environmental Mycobacteria Isolated in Ivory Coast | Chapter 04 | Recent Advances in Biological Research Vol. 3
Mycobacterium ulcerans (MU), the
causative agent of Buruli ulcer (BU), skin disease, is considered to be an
environmental pathogen. The pathogenic virulence of MU is being linked to the
expression of toxin called Mycolactone. The ketoreductase (KR) gene, is one of
the synthesis genes of mycolactone enzymes previously found in M. ulcerans.
Genetic analyses using variable number tandem repeats (VNTR) and mycobacterial
interspersed repetitive units (MIRU) have shown high diversity in M. ulcerans
and in mycolactone producing Mycobacteria (MPMs).
Aim:
The purpose of this study is to detect ketoreductase gene in the genome of
environmental mycobacteria strain, apart the M. ulcerans, from aquatic
environments in Côte d’Ivoire.
Place
and Duration of the Study: The analysis of the samples took place
in the laboratories of Institut Pasteur de Côte d’Ivoire in Abidjan City
between June 2014 and December 2015. Sampling was done in some hypoendemic and
hyperendemic sites of Buruli Ulcer of Côte d’Ivoire.
Methodology:
A total of 473 samples were collected comprising of 251 waters and 222
sediments based on sampling sites. PCR diagnostics using IS2404 and KR were
performed on strains.
Results:
20% fast growing isolated mycobacteria species
including Mycobacterium mucogenicum, Mycobacterium peregrinum and Mycobacterium
sp. was found carrying the IS2404 gene previously found in M. ulcerans. 9.23%
of strains carried the ketoreductase (KR) genes, one of the synthesis of
mycolactone enzyme.
Conclusion:
The results of this study proved the existence of ketoreductase (KR) genes in
rapidly- growing mycobacteria. This study is one of the steps taken in order to
understand different skin infections encountered in Côte d’Ivoire. Cutaneous
ulceration is a public health problem in Côte d'Ivoire. This work showed a
probable involvement of non ulcerans mycobacteria in the spread of this
disease. Investigations must therefore continue in order to confirm this
observation in clinical practice. All of which could help to determine the
likely prevalence of skin ulcers due to Mycobacterium other than M. ulcerans to
better adapt treatment in Côte d'Ivoire. This study will help to better
diagnose patients suffering from skin infections other than Buruli ulcer and to
consider strategies and means of protection of the population against all
mycobacterioses by breaking the epidemiological chain.
Author Details:
Dr Sabine N'Dri Vakou
Institut
Pasteur de Côte d’Ivoire, 01 BP 490 Abidjan, Côte d’Ivoire and University Felix
Houphouet-Boigny of Cocody, BPV 34 Abidjan, Côte d’Ivoire.
Dr. David Coulibaly N'Golo
Institut
Pasteur de Côte d’Ivoire, 01 BP 490 Abidjan, Côte d’Ivoire.
Professor Djaman Allico
Joseph
Institut
Pasteur de Côte d’Ivoire, 01 BP 490 Abidjan, Côte d’Ivoire and University Felix
Houphouet-Boigny of Cocody, BPV 34 Abidjan, Côte d’Ivoire.
Professor Dosso Mireille
Institut
Pasteur de Côte d’Ivoire, 01 BP 490 Abidjan, Côte d’Ivoire and University Felix
Houphouet-Boigny of Cocody, BPV 34 Abidjan, Côte d’Ivoire.
View Volume: https://doi.org/10.9734/bpi/rabr/v3
Comments
Post a Comment